DWM
TNXP icon

Dogwood Wealth Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Dogwood Wealth Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4K Hold
110
– – ﹤0.01% 723
2026
Q1 		$1.51K Hold
110
– – ﹤0.01% 700
2025
Q4 		$1.72K Hold
110
– – ﹤0.01% 580
2025
Q3 		$2.66K Buy
+110
New +$4.08K ﹤0.01% 491

Other funds holding TNXP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

Dogwood Wealth Management's TNXP Position: Q2 2026 in Review

Dogwood Wealth Management held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 110 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #723.

Dogwood Wealth Management first reported a position in TNXP in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.66K in Q3 2025. 13 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Dogwood Wealth Management held 110 shares of Tonix Pharmaceuticals worth $1.4K as of Q2 2026.
  • Dogwood Wealth Management left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #723 holding.
  • Dogwood Wealth Management first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Dogwood Wealth Management's Tonix Pharmaceuticals position peaked at $2.66K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.